Tag Archives: Multiple

FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with carfilzomib and dexamethasone (Kd), for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) who have received one to three prior lines of therapy. “In the Phase 3 IKEMA study, the addition… Read More »

CDC redefines coronavirus ‘close contact’ to include multiple brief exposures to virus

The Centers for Disease Control and Prevention (CDC) revised its definition of “close contact” to an individual infected with the coronavirus on Wednesday to include multiple, brief exposures adding up to over 15 minutes within 24 hours. The agency previously said close contact consisted of being within six feet of an infectious person for 15 minutes straight. The change may prompt health… Read More »

FDA Approves Sarclisa (isatuximab-irfc) for Patients with Relapsed Refractory Multiple Myeloma

FDA Approves Sarclisa (isatuximab-irfc) for Patients with Relapsed Refractory Multiple Myeloma Print this page BRIDGEWATER, N.J., March 2, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with pomalidomide and dexamethasone (pom-dex) for the treatment of adults with relapsed refractory multiple myeloma (RRMM) who have received at least… Read More »

Managing Multiple Sclerosis: Treatment Can Delay Future Attacks

January 2019 Print this issue Treatment Can Delay Future Attacks Most of the time, multiple sclerosis, or MS, starts mildly, with unpredictable symptoms that can seem baffling. Without treatment, the disease can worsen to the point that you can’t write, speak, or walk. MS starts when the body’s immune systemThe system that protects your body… Read More »